Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular zinc transport refers to the regulated movement of zinc ions across biological membranes, a process primarily executed by two major protein families: the SLC30 (ZnT) family and the SLC39 (ZIP) family [PubMed: 25310994]. The ZnT transporters function to decrease cytosolic zinc levels by exporting ions into the extracellular space or sequestering them within intracellular organelles, such as the Golgi apparatus or zincosomes [UniProt]. Conversely, ZIP transporters increase cytosolic zinc concentrations by facilitating the influx of zinc from the extracellular environment or its release from internal stores [PubMed: 25310994]. Zinc is an essential trace element that serves as a cofactor for over 3,000 proteins, making its transport vital for cellular processes including DNA synthesis, immune response, and apoptosis [NIH]. Dysregulation of these transport mechanisms is implicated in various diseases, such as Type 2 diabetes (associated with ZnT8 variants), acrodermatitis enteropathica (caused by ZIP4 mutations), and several cancers where ZIP transporters are often upregulated to support rapid cell proliferation [PubMed: 17314970, 18070915]. Pharmacological strategies targeting this system include the use of zinc ionophores like PBT2 to redistribute zinc in neurodegenerative diseases or specific transporter inhibitors to combat malignancy [PubMed: 25310994].
Modulation of zinc ion flux across cellular and organellar membranes to maintain or restore physiological zinc concentrations [PubMed: 25310994].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc transporter (Solute carrier family 30 and 39) (ZnT/ZIP).